Web1 day ago · +0.04 (2.96%) Apr 6, 2024, 4:00 PM EDT - Market closed Financials Statistics Forecast Profile Chart 1D 5D 1Y No 1Y chart data available About CLRB Cellectar Biosciences, Inc., a clinical biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of cancer. WebJun 23, 2024 · News for Cellectar Biosciences Inc. Tuesday, November 08, 2024. 11:09 AM ET. Cellectar Biosciences stock price target cut to $7.00 from $12.50 at Maxim Group MarketWatch. Wednesday, July 01, 2024. …
Cellectar Biosciences, Inc. Common Stock (CLRB) Stock Price, …
WebFLORHAM PARK, N.J., March 09, 2024 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage biopharmaceutical company focused on the discovery, development and... WebAug 1, 2005 · CLRB Cellectar Biosciences Inc 122 Follow Quote Board Chart Level 2 News Trades Financials Historical New Post About Popular Latest Posts Older abracky 12/12/22 12:44 AM Prospectus Filed... crown house north circular road
CLRB Cellectar Biosciences Inc. Stock Price & News - WSJ
WebApr 6, 2024 · CLRB Stock Overview. About the company. Cellectar Biosciences, Inc., a clinical biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of cancer. Its lead phospholipid drug conjugate (PDC) candidate is CLR 131 (iopofosine I-131), which is in Phase 2 clinical study in … WebGet Cellectar Biosciences Inc (CLRB:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. WebFind real-time CLRB - Cellectar Biosciences Inc stock quotes, company profile, news and forecasts from CNN Business. CLRB - Cellectar Biosciences Inc Stock quote - … building land for sale west midlands